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Abstract
Background: Calorie restriction (CR) is the only intervention known to extend lifespan in a wide range of organisms, including
mammals. However, the mechanisms by which it regulates mammalian aging remain largely unknown, and the involvement
of the TOR and sirtuin pathways (which regulate aging in simpler organisms) remain controversial. Additionally, females of
most mammals appear to live longer than males within species; and, although it remains unclear whether this holds true for
mice, the relationship between sex-biased and CR-induced gene expression remains largely unexplored.
Methodology/Principal Findings: We generated microarray gene expression data from livers of male mice fed high calorie
or CR diets, and we find that CR significantly changes the expression of over 3,000 genes, many between 10- and 50-fold.
We compare our data to the GenAge database of known aging-related genes and to prior microarray expression data of
genes expressed differently between male and female mice. CR generally feminizes gene expression and many of the most
significantly changed individual genes are involved in aging, hormone signaling, and p53-associated regulation of the cell
cycle and apoptosis. Among the genes showing the largest and most statistically significant CR-induced expression
differences are Ddit4, a key regulator of the TOR pathway, and Nnmt, a regulator of lifespan linked to the sirtuin pathway.
Using western analysis we confirmed post-translational inhibition of the TOR pathway.
Conclusions: Our data show that CR induces widespread gene expression changes and acts through highly evolutionarily
conserved pathways, from microorganisms to mammals, and that its life-extension effects might arise partly from a shift
toward a gene expression profile more typical of females.
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Introduction
CR reproducibly extends the maximum and average lifespans of
many different species, including some mammals [1] (for review
see [2]). Increased lifespan also has been achieved in many of the
same organisms through mutation of single genes, including key
effectors of the interrelated Insulin/Insulin-like growth factor 1
(Igf1)/Growth hormone (Gh) signaling pathways [2,3]. In the past
few years cellular signaling pathways that interact with these
hormonal pathways have yielded many mutants that extend
lifespan in non-mammals. For example, many lifespan-extending
mutations in the Akt/TOR (TOR, Target of Rapamycin, also
known as Frap1 in mice and other mammals) nutrient-sensing
pathway have been isolated in Caenorhabditis elegans, Drosophila
melanogaster, and Saccharomyces cerevisiae [4–8].
TOR is a kinase that phosphorylates Akt1 [9], and it positively
regulates translation by phosphorylation of at least two substrates:
ribosomal S6 kinase (S6K) and 4E-BP1 (Eif4ebp1), a key
translational repressor protein (for review see [10]). To date, no
lifespan experiment in mammals has demonstrated the clear
involvement of members of the TOR pathway even though this
pathway is clearly involved in nutrient sensing and metabolic
regulation, and likely plays a role in the response to CR. The
sirtuin family of proteins also regulate some aspects of aging and it
has been postulated that the life-extension benefits of CR are
regulated through either the TOR or sirtuin pathways, or possibly
both [11,12]. However, the roles of these pathways remain in
dispute [12].
Many previous aging and CR-related microarray studies have
focused on gene expression changes in liver because it is a primary
regulator of systemic metabolism, and of food energy processing,
storage, and transport, and because it secretes and regulates the
majority of circulating Igf1 [13]. Some studies have shown changes
in transcript levels of key regulatory members of the Gh/Igf1
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mechanisms governing the effects of CR in mammals to the
cellular mechanisms found in other model organisms, e.g. the
TOR pathway [16,17]. Spindler and colleagues showed that mice
begin to show persistent CR-dependent effects on liver gene
expression as early as two weeks after initiation of CR, and that a
majority of transcript changes at two weeks persist in long-term
CR [18,19]. This suggests short-term CR experiments might be
useful in connecting the underlying mechanisms of CR in mice to
those in other model organisms. However, these animals were fed
only three times a week and fasted for at least 24 hours [19] and
up to 48 hours prior to sacrifice [18]. This potentially masks
important transcript changes that routinely occur differently in
fully-fed versus CR animals, and Bauer and colleagues have shown
that starvation of these durations results in even more and larger
gene expression changes than were found in the CR studies of
Spindler and colleagues [20].
In addition to CR there is another phenotype that confers
greater longevity among many organisms, including most
mammals: female gender [21,22]. While it remains unclear
whether or not female mice live longer in general than males,
lifespans of both male and female mice are extended by CR and it
is quite clear that their lifespans are greatly influenced by sex-
associated variables, including hormonal status and reproductive
history [23,24]. It has been demonstrated that the gene expression
differences between CR and control mice are similar to the
differences found between long-lived dwarf mice and control mice,
and also similar to female mice relative to male mice [25].
However, the shortest duration CR study included in this overall
analysis consisted of 2 months of CR, the size of each of the CR
and gender comparison groups was small (n=4 and n=6,
respectively), and certain of these experimental designs included
a period of starvation prior to sacrifice. To eliminate possible
artifacts induced by starvation, Selman and colleagues employed a
16-day step-down CR protocol that avoided pre-sacrifice starva-
tion [16]. Shorter duration studies like those conducted by
Spindler and colleagues and Selman et al. have advantages over
longer studies, in allowing much more rapid progress on the
investigation of experimental regimens and compounds.
Here, we report the results of a two-week CR regimen designed
to investigate the potential of such short-term studies to influence
key gene expression changes. Importantly, prior microarray and
metabolomic studies have provided many new insights into
possible life-extension mechanisms of CR, but none has provided
a systematic analysis of expression changes of genes known or
suspected to be involved in aging-related pathways. In this study,
we address these and related issues using liver microarray data
generated from mice fed either high-calorie diets or short-term (14
days) CR diets absent prolonged starvation. Our results suggest
that CR acts at least partly through highly evolutionarily
conserved pathways, from microorganisms to mammals, and that
the lifespan-extending effects of CR appear to overlap and might
result from the lifespan-extending effects of femaleness.
Results
Dietary regimen dataset generation and statistical testing
To better understand the changes caused by CR, mice were fed
diets high (‘‘HIGHCAL’’) or low (‘‘CR’’) in calories for 14 days and
total liver RNA was used to produce expression profiles using
spotted oligonucleotide DNA microarrays. Food was administered
twice daily to reduce the complications of inducing a starvation
response, including prior to sacrifice. Body weights of most mice
stabilized after the first week and even the weights of most CR mice
reached plateau by 7 to 9 days after initiation of CR. After
background threshold adjustment and normalization our micro-
arrays detected 8,347 non-redundant genes. To statistically test
which genes are associated with CR relative to high calorie feeding,
we used Significance Analysis of Microarrays (SAM) [26]. SAM
performs a moderated t-test on two user-selected groups of
microarray datasets, and returns a set of discriminant genes ranked
in descending order by d, the t-statistic, and calculates a false
discovery rate (FDR) based on random permutations of the data
labels (see Methods). SAM also reports the q-value for each ordered
gene (the lowest FDR at which the gene is called significant) and
several other measures including fold-change values for each gene.
At a restrictive cutoff of q,0.01, 1,897 of 8,347 detected genes
(22.7%) differed between CR and HIGHCAL (3,855 genes
(46.2%) at the permissive cutoff of q,0.1). As shown in Table
S1, Quantitative RT-PCR (Q-RT-PCR) confirmed direction of
change (up or down) of 18 transcripts called by SAM as
differentially expressed, and fold change values in most cases
were larger for Q-RT-PCR (subsequent fold changes given are
microarray values). The 90
th percentile number of median false
positives at the permissive cutoff is about 634 genes. This suggests
that even without considering the false negative rate the number of
true positive genes changed significantly by CR can be
conservatively estimated to be over 3,000. All genes called as
significant at both cutoffs are listed in Table S2. Of the 1,897
genes changed by CR at q,0.01, 827 (43.6%) are upregulated and
1,070 (56.4%) are downregulated relative to HIGHCAL (at
q,0.1, 1,693 (43.9%) are upregulated and 2,162 (56.1%) are
downregulated). Figure 1 shows all 3,855 genes in the permissive
list (cutoff q,0.1) in a plot of significance (absolute value of d,| d|)
versus log2 fold change. The shape of this plot shows that even
Figure 1. Plot of significance versus fold change of all
significant genes. Plot of significance (absolute value of d, |d|) versus
log2 fold change, for all 3,855 genes called significant at q,0.1. Ddit4,
the gene with the highest significance score, is shown at upper right.
doi:10.1371/journal.pone.0005242.g001
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lated genes show greater fold-changes and |d| scores than
downregulated genes. Overall, 27 genes were upregulated more
than 10-fold, while only 4 genes were downregulated more than
10-fold. This general asymmetry held true irrespective of the
normalization method used.
CR alters expression of key regulatory genes in conserved
aging-related pathways
As highlighted in Figure 1, the single most significant and one of
the most fold-changed discriminant genes is DNA-damage
inducible transcript 4 (Ddit4), a p53-regulated negative regulator
of the Frap1 pathway [27], which is increased by CR by over 33-
fold (80.1-fold as measured by Q-RT-PCR). In addition, brief visual
inspection of the significance-ranked list of genes reveals that many
other top-ranked genes are involved in a variety of processes related
to aging, hormonal synthesis and signaling, cell cycle regulation and
apoptosis. To begin to further analyze these classes of significant
genes in a systematic way we determined the intersection of these
genes with the human and mouse genes listed in the GenAge
database [28]. As described below, analyses for enriched Gene
Ontology (GO) terms confirmed many of the broader general
categories observed by visual inspection, however, GO terms and
even GenAge annotations currently are too coarse to capture
certain aging-related classes of genes and processes. One important
excluded class among GO terms is genes that are known members
of aging-related pathways but which have not been isolated as
mutants that alter lifespan; key regulators of these pathways are of
particular importance. The GenAge database includes many such
genes. Table 1 lists the intersection of our set of 1,897 significant
genes (q,0.01) with the set of 265 non-redundant mouse and
human genes listed in GenAge plus seven selected genes of this type
that are not listed in GenAge but are among the most significant
differentially expressed genes in our data.
Among aging-related genes upregulated by CR are leptin
receptor (Lepr), cathepsin L (Ctsl), plasminogen activator urokinase
(Plau), cyclin-dependent kinase inhibitor 1A (Cdkn1a) (a.k.a. p21/
Cip), nicotinamide N-methyltransferase (Nnmt), peroxisome prolif-
erative activated receptor, gamma, coactivator 1 alpha (Ppargc1a)
(a.k.a. Pgc-1 alpha), serum/glucocorticoid regulated kinase 1 (Sgk1),
and two Cebp paralogs: CCAAT/enhancer binding protein delta
(Cebpd) and CCAAT/enhancer binding protein beta (Cebpb).
Downregulated genes include aprataxin (Aptx), telomerase reverse
transcriptase (Tert), insulin-like growth factor binding protein, acid
labile subunit (Igfals), and growth hormone receptor (Ghr). Lepr was
upregulated by over 58-fold by CR (49.3-fold by Q-RT-PCR) and
was third in the list of genes ranked by significance. An increase in
Lepr transcript abundance was somewhat expected since this is a
reported result of CR [29] and of starvation [20] but the increase
we observed was about 10-fold greater than seen in these previous
reports. All of the genes in these lists are of possible importance in
the life-extension response to CR but the large fold changes, high
statistical ranks, and known roles in key aging-regulatory pathways
make Ddit4, Nnmt1 and Cdkn1a especially interesting.
4E-BP1 phosphorylation is reduced by CR
The large increase inexpressionof Ddit4 suggests inhibition of the
Frap1 (TOR) pathway by CR. Frap1 is a protein kinase whose
currently known substrates include the kinases Akt1 and S6K1, and
the translation regulatory protein Eif4ebp1 [9,10]. Recent data
suggest Frap1 enhances initiation of59-cap-dependent translation of
most mRNA species by phosphorylation of Eif4ebp1, promoting its
dissociation from the translation initiation factor Eif4e [30,31].
Several sites on Eif4ebp1 are phosphorylated but phosphorylation
of Thr69 (human Thr70) is a primary determinant of this
dissociation [31]. Phosphorylation of S6K1 on Thr390 (human
Thr389) is a primary activator of its kinase activity and appears to
regulate translation of ribosome-related transcripts and ribosome
biogenesis, although the mechanism underlying differential regula-
tion of phosphorylation of Eif4ebp1 and S6K1 by Frap1 is currently
unknown [31]. Ddit4 has been shown to strongly inhibit Frap1
activity [32] and simply overexpressing Ddit4 is sufficient for this
inhibition [33]. Therefore, the over 33-fold increase of the Ddit4
transcript in CR mice suggested a reduction of phosphorylated
isoforms of substrates of Frap1 in livers of these mice.
To test this hypothesis we performed Western blots on Eif4ebp1
and S6K. Two primary isoforms of S6K1, p70 and p90, were
detected in our liver samples. We assayed Thr390 of p70 (Thr412
of p90), and for Eif4ebp1 we assayed Thr69, which are recognized
targets of phosphorylation by Frap1. Consistent with the current
model of the regulation of Eif4ebp1 by Frap1, Thr69 phosphor-
ylation of Eif4ebp1 was increased more than 2-fold by high calorie
feeding relative to CR (Figure 2)( P=6.0610
24, one-sided
Wilcoxon rank sum test). In contrast, the Thr390 phosphorylated
p70 isoform of S6k1 was undetectable in our liver samples,
including those from TAL-fed mice, while Thr412 of p90 was
detected but no significant change was found in HIGHCAL
relative to CR mice. These results suggest that CR results in
reduced efficiency of initiation of cap-dependent translation
through phosphorylation of 4EBP1 but does not significantly alter
processes dependent upon phosphorylation of S6K1, such as
translation of ribosomal transcripts and ribosome biogenesis [34].
CR alters gene expression within specific gene classes
To further understand and quantify enriched classes of genes
significantly upregulated or downregulated by CR we employed the
GO analysis tool FuncAssociate [35], which returns all overrepre-
sented GO terms for a given set of input genes. We separately
analyzed upregulated, downregulated, and the combined upregu-
lated and downregulated sets of genes using both permissive and
restrictive cutoffs for a total of 6 separate analyses. The number of
terms returned for each of the upregulated (U), downregulated (D),
and combined upregulated and downregulated (C) sets of genes are
as follows: at the restrictive cutoff q,0.01 U=57, D=61, and
C=103; at the permissive cutoff q,0.1 U=94, D=99, and
C=170. All GO terms and statistics can be seen in Table S3.
To more clearly understand the changes in biological function
that result from changes in gene expression, for each GO term we
plotted in a stacked bar graph the relative fraction of upregulated
and downregulated genes associated with that GO term from the
SAM output (q,0.1). Figure 3 shows a selection (culled to
eliminate excessive redundancy) of the GO terms with the largest
fractions of upregulated or downregulated genes. CR results in a
clear relative upregulation of genes involved in protein biosynthe-
sis, rRNA processing, mRNA metabolism and splicing, ribosome,
and regulation of protein translation. Many GO categories consist
mostly of downregulated genes including those involved in
mitochondria, carboxylic acid metabolism, DNA replication,
steroid, cholesterol and lipid metabolism, lysosome, peroxisome,
and glutathione S-transferase activity. Several downregulated GO
classes are involved in protein turnover including endoplasmic
reticulum/ER, isomerase activity, amino acid derivative biosyn-
thesis, protein positioning, and the proteasome.
CR feminizes gene expression overall and within specific
gene classes
Since genes involved in hormone biosynthesis are generally
downregulated in our data and several genes previously demon-
CR Feminizes Gene Expression
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Gene Gene name
Fold
Change FC Rank Stat Rank Function
Ddit4* DNA-damage-inducible transcript 4 33.3 6 1 Frap1 (mTOR) inhibitory tumor suppressor
Lepr Leptin receptor 58.4 3 2 Regulator of adiposity and metabolism
Aptx Aprataxin 22.3 139 6 DNA repair, binds Parp1, Xrcc1, Xrcc4, p53
Cebpd* CCAAT/enhancer binding protein delta 4.3 74 12 Mouse paralog swap increases lifespan
Ctsl* Cathepsin L 4.9 66 14 Activates Plau by proteolytic cleavage
Cdkn1a Cyclin-dependent kinase inhibitor 1A (P21) 10.2 26 24 Key negative regulator of cell cycle
Nnmt* Nicotinamide N-methyltransferase 36.5 5 26 Yeast ortholog NNT1 mediates response to CR
Ppargc1a* Ppargc1a, aka Pgc1-alpha 6.0 52 55 Sirt1-interacting regulator of metabolism
Ctgf Connective tissue growth factor 3.3 97 64 Vascular growth factor; role in aging speculative
Cebpb CCAAT/enhancer binding protein beta 2.2 212 82 Replacing Cebpa with Cebpb extends lifespan
Tert Telomerase reverse transcriptase 22.9 76 88 Telomerase reverse transcriptase
Plau Plasminogen activator, urokinase 2.7 144 92 Overexpression in mice extends lifespan
Sgk1* Serum/glucocorticoid regulated kinase 4.6 72 94 C. elegans ortholog mutation increases lifespan
Map3k5 Mitogen activated protein kinase kinase kinase 5 2.0 274 107 Involved in stress response and apoptosis
Ar Androgen receptor 22.8 79 132 Androgen receptor; dihydrotestosterone receptor
Igfals* Insulin-like growth factor binding protein ALS 22.4 116 133 Regulator of Igf1 signaling
Blm Bloom syndrome homolog (human) 4.7 67 186 Involved in DNA repair; Wrn paralog
Ghr Growth hormone receptor 22.1 186 190 Mutation increases mouse lifespan
Flt1 FMS-like tyrosine kinase 1 1.4 658 194 Receptor for Vegf
Foxo1 Forkhead box O1 1.5 540 228 Ortholog of lifespan-extending C. elegans daf16
Nr3c1 Nuclear receptor subfamily 3 21.5 647 233 Glucocorticoid receptor
Stat3 Signal transducer and activator of transcription 3 1.7 414 233 Signal transducer and activator of transcription 3
Tnfrsf6 Tumor necrosis factor receptor superfamily 21.5 682 244 Fas; roles in apoptosis, development and cancer
Jak2 Janus kinase 2 21.4 854 246 Associated with many genes linked to aging
Ercc3 Ercc3 21.3 1079 265 Involved in DNA repair
Gsta4 Glutathione S-transferase 21.7 393 271 Involved in oxidative protection
Gclc Glutamate-cysteine ligase 22.0 230 316 Overexpression in fruitflies extends lifespan
Jun Jun oncogene 2.1 237 328 Pathway regulates aging in fruitflies and worms
Nfkbia Nfkb inhibitor 1.5 513 339 Inhibitor of NF-kappa-B
Txn1 Thioredoxin 1 21.5 716 350 Overexpression in mice extends lifespan
Sncg Synuclein 22.0 237 354 Synuclein, gamma
Mapk9 Mitogen activated protein kinase 9 21.3 1142 395 Regulator of apoptosis and stress response
Ppara Peroxisome proliferator activated receptor alpha 22.3 131 414 Regulates fatty acid metabolism
Foxo3 Forkhead box O3 1.5 511 421 Orthologs regulate aging in fruitflies and worms
Egfr Epidermal growth factor receptor 1.7 420 432 Regulator of cellular proliferation
Top2a Topoisomerase (DNA) II alpha 21.5 596 465 Topoisomerase indirectly linked to Wrn and Atm
Hspa8 Heat shock protein 8 1.6 467 466 Heat shock 70 kDa protein 8
Tfdp1 Transcription factor Dp 1 21.3 1203 527 Involved in cell senescence, cell cycle, apoptosis
Lmnb1 Lamin B1 21.5 644 593 Part of nuclear lamina, interacts with Lmna1
Pdpk1 3-phosphoinositide dependent protein kinase-1 1.3 1114 594 Phosphorylates and activates AKT1
Cat Catalase 22.0 216 623 Overexpression extends mouse lifespan
Cebpa CCAAT/enhancer binding protein alpha 21.6 424 698 Replacing Cebpa with Cebpb extends lifespan
Vcp Valosin containing protein 21.3 1359 710 ER protein/regulator of protein aggregation
Gclm Glutamate-cysteine ligase 21.5 580 841 Overexpression in fruitflies extends lifespan
Pik3r1 Phosphatidylinositol 3-kinase 21.4 799 857 Involved in metabolism and insulin signaling
Arhgap1 Rho gtpase activating protein 1 21.3 1250 884 Androgen receptor; dihydrotestosterone receptor
Apex1 Apurinic/apyrimidinic endonuclease 1 21.3 1357 1001 Repairs oxidative DNA damage
Xrcc5 Xrcc5 21.3 1241 1017 Involved in DNA repair /chromatin remodeling
Mapk3 Mitogen activated protein kinase 3 21.2 1683 1063 Involved in stress response signaling
Genes are upregulated (positive fold-change values) or downregulated by CR, and are listed in the GenAge mouse and human database except for seven manually
selected genes marked with an asterisk (*). Aging-related annotations come from GenAge [28] and other annotations come from Entrez Gene [73]. Fold change (FC)
rank and statistical (Stat) ranks from SAM; separate statistical ranks are given for upregulated and downregulated genes.
doi:10.1371/journal.pone.0005242.t001
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top of our statistical and fold-change rankings, we suspected CR
might have an overall feminizing effect on gene expression. To test
this hypothesis we compared our data to the male versus female
liver expression microarray data of Yang and colleagues which
were collected using 334 total microarrays (one microarray per
liver sample; 165 male and 169 female mice) [36]. Of the 1,897
genes in our restrictive list, 872 were found in their study to be
more highly expressed in either male or female (1,711 of 3,855
genes in our permissive list).
Figure 4 displays the frequencies (at both permissive and
restrictive cutoffs) of each of four classes of genes: increased by CR
and more highly expressed (UP) in females, increased by CR and
UP in males, decreased by CR and displaying lower expression
(DOWN) in females, and decreased by CR and DOWN in males.
The percentage of genes displaying feminized expression is higher
among the set of genes upregulated in CR than among genes
downregulated in CR. Separate Chi-square analyses of CR-
upregulated genes and CR-downregulated genes at both the
restrictive and permissive cutoffs show a significant bias toward a
female pattern of expression. We also used FuncAssociate to
determine the overrepresented GO category associations of each
of these four gene sets. As shown in Table 2, genes downregulated
and masculinized by CR are involved in immune response; genes
upregulated and feminized by CR are involved in general
metabolism and protein biosynthesis; and genes downregulated
and feminized by CR are involved in enzymatic catalysis, and
protein modification and transport through the Golgi and
endoplasmic reticulum. These results suggest that CR has a
generally feminizing effect on gene expression, which involves
protein metabolism and turnover, which might contribute to the
lifespan extension effects of CR.
Discussion
A primary focus of biomarker and lifespan studies has been
calorie restriction (CR). Spindler and colleagues first showed that
two weeks of CR (40% reduction relative to ad libitum) causes
many changes in mouse gene expression that persist in the long
term [19]. But the small number of increased or decreased
transcripts found in their experiments, prolonged periods of
starvation of animals including prior to sacrifice, and a report by
Bauer and colleagues showing that a greater number of transcripts
are changed by starvation alone highlighted the need for a strategy
to minimize starvation [19,20]. Selman and colleagues subse-
quently utilized a 16-day CR protocol that steps down from 90%,
to 80%, and finally to 70% caloric intake (30% CR), and which
avoids pre-sacrifice starvation. We employed a hybrid strategy that
utilizes a CR treatment similar to that administered by Spindler
and colleagues (approximately 40% CR for 2 weeks), but that
avoids the induction of a starvation response. To enrich for
chronic CR-related gene expression responses and to minimize the
starvation response, we fed mice twice daily, including about half a
day prior to sacrifice. This approach is more consistent with CR
assays in organisms with constant food access, including yeast,
nematodes, and fruitflies. Using this approach we found that CR
alters liver expression of at least 3,000 genes. Comparisons of lists
of genes most significantly associated with CR to those listed in
GenAge allowed us to systematically discover important aging
regulatory genes in our data, although current limitations of both
GenAge and Gene Ontology annotations motivated a search for
additional aging-related genes among the genes displaying the
most significant expression differences between CR and high-
calorie feeding.
Nnmt, Cdkn1a, and Ddit4 are of particular interest because of
their high statistical rankings, large fold-changes and because all
three appear to play key roles in aging regulatory pathways. Other
notable upregulated genes are Lepr, Cebpd, Cebpb, Ctsl, Plau, Sgk1,
and Ppargc1a (Pgc-1 alpha), and notable downregulated genes
include Aptx, Tert, Igfals and Ghr. Previous microarray studies of
CR have shown changes in Ddit4, Ghr [29] and Sgk1 [37] but not in
most of these other genes. Bauer and colleagues reported the
upregulation of leptin receptor (Lepr) with starvation, and in our
data it is upregulated about 50-fold as measured by both
microarray and Q-RT-PCR [20]. Leptin is closely associated
with the neuroendocrine responses of starvation, CR, and body
size [38]; however, the direct role of leptin in aging and its
modulation by CR remain uncertain, but a primary regulatory
role of leptin in the adaptive response of CR has been proposed
[39]. Two pairs of these genes are notable because they are
functionally related. Ctsl encodes a protease that cleaves Plau, and
Cebpd and Cebpb are paralogs (they are also homologs of Cebpa,
which appears farther down Table 1). Neither Ctsl nor Cebpd has
been directly implicated in aging; however, our results suggest they
might be involved in the lifespan regulation observed in mutants in
the other member of these pairs.
Both Ppargc1a and Nnmt have been shown to function in sirtuin-
related pathways. Ppargc1a is a multifunctional regulator of
metabolism and mitochondrial biogenesis, and has been linked
to regulation of glucose homeostasis, CR and a possible role in
aging through a physical interaction with Sirt1 in liver [40]. Nnmt
encodes Nicotinamide N-methyl transferase which produces N1-
methyl nicotinamide from the vitamin B3 precursor nicotinamide.
Nicotinamide partly or completely abrogates yeast lifespan
Figure 2. CR-induced phosphorylation changes in Eif4ebp1. Western blots of unphosphorylated Eif4ebp1 (4EBP1) and Thr69 phosphorylated
Eif4ebp1 (p4EBP1) for calorie restricted (CR) and high-calorie-fed (HIGHCAL) mice. Labels at top indicate individual mouse sample codes. CR, Calorie
Restriction; FHC, Fixed High Calorie feeding; TAL, True Ad Libitum feeding. TAL1, TAL3, and TAL4 are from livers used to make the RNA pool TAL-P.
CR1, CR7, and CR8 are from livers used to make the RNA pool CR-P1. CR4, CR5, and CR6 are from livers used to make the RNA pool CR-P2. FHC3 and
FHC3B are separate samplings of the same liver.
doi:10.1371/journal.pone.0005242.g002
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expression in the data of Yang et al. Percent numbers are percent of all genes displaying both specific directional changes from CR and sexually
dimorphic expression and corresponding numbers of genes in each of these four classes are given in parentheses. Deviation from expected
frequencies was determined by a chi-square test for upregulated genes and separately for downregulated genes, at each q-value cutoff.
doi:10.1371/journal.pone.0005242.g004
Figure 3. GO categories with largest relative fractions of upregulated or downregulated genes. Each stacked bar graph displays the
relative upregulated or downregulated fractions of the total number of genes (n=100%) significantly altered by CR within a given GO category
returned by FuncAssociate (adjusted p,0.05). The upregulated fraction is shown in red and the downregulated fraction is shown in blue.
doi:10.1371/journal.pone.0005242.g003
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competitive inhibitor of the Sir2 protein [41,42]. Overexpression
of human NNMT in yeast increases rDNA silencing, a phenom-
enon linked to sirtuin-mediated extension of life span [41].
Overexpression in yeast of NNT1, the yeast homolog of Nnmt, also
increases rDNA silencing, increases lifespan which is not further
increased by glucose restriction, and restores full lifespan extension
by calorie restriction in a pnc1 mutant [41,42]. Tsuchiya and
colleagues showed that elevated nicotinamide blocks CR-induced
lifespan extension in yeast lacking sirtuins [43]. This suggests a
Sir2-independent mechanism for abrogation of lifespan extension
by nicotinamide. Taken together, these results suggest that NNT1
overexpression in yeast recapitulates a Sir2-independent life
extension mechanism governed by CR. Our data showing that
its mammalian homolog, Nnmt, is among the most statistically
significant and most upregulated genes (increased by approxi-
mately 48-fold as measured by Q-RT-PCR) in response to CR,
strongly suggests that CR in mammals might be mediated by a
similar and highly evolutionarily conserved mechanism.
Our results confirm those of others suggesting that regulation of
DNA replication and repair, apoptosis, and cell proliferation play
important roles in the CR response. Aprataxin (Aptx) is one of the
most significant downregulated genes and is involved in the repair
of multiple types of DNA lesions and interacts with the DNA
repair and stress-response proteins Parp1, Xrcc1, Xrcc4, and p53.
The p53-regulated key regulator of apoptosis and cell cycle
progression Cdkn1a (increased by approximately 22-fold as
measured by Q-RT-PCR) is among the most significant
upregulated transcripts in our data and is regulated post-
translationally by Akt phosphorylation [44,45]. Telomerase
reverse transcriptase (encoded by Tert, decreased by approximately
2.9-fold) is also a key regulator of cell proliferation and apoptosis,
and has been found in a multiprotein complex with Akt, S6K and
Frap1 (TOR) [46].
The Frap1 pathway genes Ddit4 and Sgk1 also have not
previously been shown to be involved in regulating aging in
mammals. However, it has been shown that Ddit4 expression
changes in response to CR in both rats and mice [16,17], that the
Akt/TOR pathway regulates lifespan in multiple species [4,5,7,8],
that Sgk1 acts in this pathway to regulate nematode lifespan [6],
and that Ddit4 regulates this pathway in mammals [32,47]. In C.
elegans SGK-1 acts to mediate DAF-2/Igf1 signaling in a complex
with Akt kinases and partial deletion or knockdown of SGK-1
increases lifespan [6]. The expression of Ddit4 is regulated by
hypoxia, cellular energy stress, and by p53 and p63 in response to
DNA damage and reactive oxygen species (ROS) [33,47,48]. Ddit4
and its paralog Ddit4l are evolutionarily conserved and the fruitfly
orthologs Scylla and Charybdis appear to function in a similar
manner. Overexpression of Scylla and/or Charybdis results in
smaller cell size and small flies, and loss of both genes results in
larger cells and flies [49].
Recent data from Ellisen and colleagues suggest that a primary
Ddit4 mechanism of action is to competitively bind inhibitory 14-3-
3 proteins that otherwise bind to the Tsc2 protein, part of the
tuberous sclerosis complex that inhibits Akt/Frap1 signaling when
Tsc2 is unbound [32]. Hypoxia or energy stress triggers the
binding of 14-3-3 proteins by Ddit4, freeing Tsc2 to suppress
Frap1 kinase activity and reduce phosphorylation of its substrates.
These authors showed that mouse embryo fibroblasts (MEFs)
deleted for Ddit4 demonstrate increased proliferation and
anchorage-independent growth resulting from dysregulation of
Akt/Frap1 pathway signaling [32]. They further demonstrated
that Ddit4-mediated inhibition of Frap1 occurs even in the
presence of constitutive Akt activation. Subcutaneous injection
into nude mice of MEFs containing constitutively activated Akt
results in slow-growing tumors, and the additional deletion of Ddit4
causes much more rapid tumor growth. These data suggest that
Ddit4 is a tumor suppressor acting on the Frap1 pathway
downstream of Akt, and Ddit4 downregulation has recently been
described in a subset of human cancers [32].
Since overexpression of Ddit4 in cultured mouse cells is sufficient
to inhibit activation of the Frap1 pathway, greatly reducing
phosphorylation of S6K1 and ribosomal protein S6 [33], the over
33-fold increase that CR elicits in Ddit4 in our experiments
suggested a strong CR-dependent downregulation of Frap1
signaling in liver. This was confirmed by Western blots of Thr69
of Eif4ebp1 [47,50]. Sharp and Bartke also found decreased
phosphorylation of Eif4ebp1 in livers of Ames (Prop1df) dwarf
mice, but they also found decreased phosphorylation of the p70
and p85/p90 isoforms of ribosomal S6K [51]. Jiang and
colleagues also reported decreased phosphorylation of Thr389 of
liver p70S6K in rats undergoing 4-week CR, as well as decreases
in overall Frap1 kinase activity and phosphorylation of critical
residues on Eif4ebp1, Akt and Tsc2 [52]. We did not find S6K to
be differentially phosphorylated between CR and HIGHCAL
mice. This result needs to be investigated further since
Table 2. GO categories associated with groups of genes displaying CR-regulated and sex-biased expression.
Genes UPREGULATED in CR Genes DOWNREGULATED in CR
CR and Female UP CR and Female DOWN
Overrepresented GO Attributes Overrepresented GO Attributes
P-adj Number GO Attribute P-adj Number GO Attribute
,0.001 31 0005840: ribosome 0.001 42 0005783: endoplasmic reticulum
,0.001 64 0009058: biosynthesis 0.023 32 0005794: Golgi apparatus
,0.001 217 0008152: metabolism 0.031 199 0003824: catalytic activity
CR and Male UP CR and Male DOWN
Overrepresented GO Attributes Overrepresented GO Attributes
P-adj Number GO Attribute P-adj Number GO Attribute
- - NONE ,0.001 34 0006952: defense response
Columns display GO attribute categories associated with genes upregulated or downregulated in CR (q,0.1) and also relatively upregulated in either female or male sex
according to the data of Yang et al. [36]. Adjusted p-values and number of genes are given for each category.
doi:10.1371/journal.pone.0005242.t002
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Frap1, was not detectable in our samples, and it therefore appears
that phosphorylation of p70 and p90 isoforms are differently
regulated from one another, and from Eif4ebp1. Nevertheless,
increased phosphorylation of Eif4ebp1 and the large increase in
the Ddit4 mRNA transcript together suggest CR results in
inhibition of the Frap1 pathway in liver to inhibit translational
initiation. It will be of interest to determine which of these
observed post-translational changes persist in long-term CR.
Dhahbi and colleagues have shown that certain genes display
oscillatory expression over the initial weeks of CR [19]. Thus, it is
possible or even likely that key post-translational modifications also
oscillate, or that the 2-week CR protocol used in this and similar
studies is too short to induce important post-translational and
other phenotypic alterations that occur in long-term CR.
Our GO analysis shows that CR results in relative upregulation
of genes within GO categories associated with ribosomes,
translation initiation and elongation, and protein biosynthesis,
suggesting that protein biosynthesis and processing machinery
remain at fairly high levels. Our Western blot data suggest that
translation is more tightly regulated through Frap1-dependent
phosphorylation events. It is quite interesting that genes encoding
ribosomal proteins and translation initiation and elongation factors
are almost uniformly upregulated in response to CR, but
translation appears to be downregulated. These findings are
consistent with the possibility that many of the effects of CR are
mediated to some degree through the control of protein synthesis
and degradation. This possibility is supported by the findings that
lifespan can be extended by mutations in translational regulatory
proteins and in many individual ribosomal proteins in both yeast
and C. elegans (see [53] for review), and less directly in more
complex organisms by the observation that tryptophan restriction
extends lifespan in rats [54] and methionine restriction extends
lifespan in both rats and mice [55,56]. Consistent with this model,
downregulated GO categories in our data include several involved
in protein turnover including endoplasmic reticulum/ER, isom-
erase activity, amino acid derivative biosynthesis, proteasome core
complex, and protein positioning and transport.
Our GO analysis also shows that CR results in relative
downregulation of genes within GO categories associated with
peroxisomes, lysosomes, mitochondria, and metabolism of lipids,
cholesterol, and steroid hormones. Our results are in some cases
consistent with but also contrast the GO analyses reported by
Selman and colleagues resulting from mice treated with acute CR
for 16 days [16]. They also found that genes involved in lipid and
steroid metabolism were upregulated but in contrast to our results
they found a subset of lipid metabolism genes downregulated; they
found the GO category for lipid metabolism (GO:0006629) among
both upregulated and downregulated categories. Also in opposi-
tion to our findings, they found mitochondrion (GO:0005739) and
membrane fraction (GO: 0005624) to be upregulated categories,
and metabolism (GO:0008152) to be downregulated. However, we
found a much larger number of differentially expressed genes in
each category, which might provide an explanation for these
discrepancies. For example, even at the restrictive cutoff used in
our analysis there are 345 differentially expressed genes in the
metabolism GO category compared to 181 in their data. These
additional genes might be responsible for the disparate findings.
Our results also show a clear alteration in hormone biosynthesis
and suggest that even short-term CR biases expression changes
toward a more feminine profile. This hypothesis was confirmed by
comparing our data to the whole-genome survey of sexually
dimorphic gene expression performed by Yang and colleagues on
165 male and 169 female mice [36]. This confirms the findings
made by Swindell in an analysis of longer duration (between 2 and
17 months) CR experiments on male mice, and sexually
dimorphic expression on small groups of female and male mice
(n=6 in each group) [25]. Overall, our results showing
downregulation of genes involved in sterol, steroid, and sex
hormone production by CR suggest a possible primary or
significant contributory mechanism for some of the hormonal
changes in response to CR in several species, including humans.
Even more importantly, these changes further tie CR to key
hormonal and cellular effectors of aging in model organisms, and
possibly even in humans, since in humans and most other
mammals females live longer than males [21,22].
However, even though CR extends lifespan in both male and
female mice there are two primary barriers to establishing simple
relationships between CR, gender, hormones, and lifespan, and
extrapolating mouse and other rodent results to humans and other
primates: 1) there is clear disagreement among prior reports
regarding the effects of CR on various hormone levels in rodents,
humans and other primates [57–60]; and, 2) there is disagreement
among previous studies regarding gender effects on mouse
lifespan. Reports of CR-induced changes of important hormone
biomarkers such as GH, IGF1, and DHEA-S (dehydroepiandros-
terone sulfate) are variable across and even within species. These
variable results are counterbalanced somewhat by the fact that the
effects of CR on insulin levels and the insulin axis appear to be
mostly consistent across species [57,60]. Insulin is a key longevity
biomarker but the insulin axis is complex and is regulated by many
other hormones, including sex and adrenocortical hormones [60].
Importantly, it remains unclear whether or not there are gender
differences in mouse lifespan. One large and early study suggests
females live longer than males, especially virgin females [24]. This
study from the Jackson Labs remains among the largest, with data
on thousands of mice, but later data from this same facility cast
doubt on these prior results, as improved conditions allowed far
greater lifespans [24]. More recent but still unpublished data from
this facility on 3,744 mice of 32 different laboratory strains suggest
that females might not live longer [61], supporting prior data
presented by others including Ingram et al. [62]. Until final data
from this and other high-quality studies are published, whether or
not there is a difference between male and female mouse lifespan
will remain an open question. Nevertheless, our data raise some
intriguing questions including 1) are hormonal aspects or other
determinants of gender also important regulators of lifespan; and
2) what might be the effect of CR on gene expression in female
mice? It is possible that the response will be similar to what we
found in male mice, i.e. many of the same genes will change in a
trajectory away from male expression levels. It will be important to
test this possibility and determine whether or not CR induces
feminizing gene expression changes in organisms that have a clear
female lifespan advantage, such as humans, and whether such
changes might influence lifespan.
Materials and Methods
Animals and dietary regimens
Nine-month-old retired breeder ICR male mice were obtained
from Harlan Breeders (Indianapolis, IN). Animals were kept in a
positively pressurized HEPA air-filtered animal room with 12-hour
light/dark cycles. A total of 35 mice were fed 3 specified dietary
regimens. Six mice were fed a True Ad Libitum (TAL) diet of
which they ate as much as they desired, 12 mice were fed calorie-
restricted diets of 73 kcals per week (CR), and 17 mice were fed a
diet of 110 kcals per week (Fixed High Calorie, FHC). Recovered
food from TAL mice suggested an average consumption plus loss
CR Feminizes Gene Expression
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lost in bedding, and a more accurate estimate is probably between
120 and 130 kcal/week. Therefore, we estimate the approximate
percent calorie reduction for each fixed-calorie diet relative to
TAL is 10% to 15% for FHC and 40% to 45% for CR. Calorie
reduction of CR relative to FHC is 34%. All mice were given non-
acidified water ad libitum throughout regimen treatment.
Mice were fed freshly hydrated food every twelve hours at the
beginning and end of the light cycle. Purified diets differing in caloric
composition but similar in macronutrient ratios to AIN-93M (Diet
No. F05312, Bioserv, Frenchtown, NJ) were assembled from
individual ingredients and vitamin and mineral mixes (Bio-Serv,
Frenchtown, NJ). These diets consisted of the following approximate
caloric composition: 10% fat, 15% protein, and 75% carbohydrate.
Animalswere fed 12 to 16 hours prior to sacrifice and remaining food
was removed after feeding FHC and TAL mice. Animals were
sacrificed by rapid decapitation. Tissues were immediately harvested
and flash frozen in liquid nitrogen, placed in polypropylene tubes and
placed in cryogenic storage for future processing. All animal housing
and experiments were performed in compliance with prevailing local,
state, and federal regulations of Waltham, MA, USA, and according
to the guidelines of Suckow etal. [63] and the Institute for Laboratory
Animal Research (ILAR) [64].
To assess the possibility of minimizing expenses over the long-
term some RNA samples were combined into pools of 3 prior to
cDNA synthesis and hybridization to single microarrays. Pooling
of RNA samples for microarray analysis has been reported to
reduce intrasample variance and results in averaging of most
genes, but does not otherwise affect the analysis [65]. In our
experiments all microarrays of pooled samples were analyzed
identically with microarrays from individual samples. The 8 CR
microarrays consist of 6 microarrays from individual samples and
2 microarrays each produced using pooled RNA samples from 3
other individual mice. The 15 high calorie microarrays consist of 3
individual and 1 pool of TAL samples and 8 individual and 3
pooled FHC samples.
Microarray experiments
Spotted, long oligonucleotide microarrays representing
,19,000 genes, duplicates and controls (17,752 non-redundant
genes and ESTs) were used to interrogate mRNA abundance
(GEO platform accession GPL6761; GEO Samples GSM283874
through GSM283896). The oligonucleotide library was designed
by Compugen and manufactured by Sigma-Genosys. Liver
samples were taken from cryogenic storage and fragmented in
liquid nitrogen. Total RNA was purified by Qiagen RNeasy Mini
kit. Briefly, several small pieces totaling 200 mg taken from
different locations from an individual liver were homogenized in
Qiagen guanidine isothiocyanate lysis buffer, and then subsequent
steps were performed according to the Qiagen protocol. All pools
of RNA were made by combining equal amounts of each
individual RNA sample subsequent to purification and quantifi-
cation of RNA samples from the individual livers. Microarray
design and preparation, sample labeling, and microarray hybrid-
ization and scanning services were performed by the Harvard
Partners Center for Genetics and Genomics (now Partners Center
for Personalized Genetic Medicine). Stratagene Universal Mouse
Reference RNA was chosen as a control for two-color hybridiza-
tion [66]. Fluorescent labels were incorporated directly during
cDNA synthesis using the ChipShot direct labeling and cleanup
system according to the manufacturer’s instructions (Promega,
Madison, WI). Total liver RNA was labeled with Cy3 and control
RNA was labeled with Cy5. Following dye incorporation and
sample cleanup, sample cDNA and control cDNA were mixed
together with spiked controls that aid in hybridization calibration,
and then the mixed sample was hybridized to the microarray
surface using a Maui Hybridization System (Biomicro, Salt Lake
City, UT). Microarrays were washed and scanned at 532 nm and
635 nm wavelengths on an Axon 4000B microarray scanner
(Axon Instruments, Union City, CA).
Microarray data collection, processing, and analysis
Scanned data were collected and processed using GenePix 4.1
software (Axon Instruments, Union City, CA). Genes with median
spot intensities below 50 for liver expression for both CR and
HIGHCAL were culled from the data set to give a set of 9,550 genes
and controls for normalization. These culled data were normalized
using the CARMAweb implementation of the limma package for R.
Median background was subtracted from median foreground signal
using the normexp method followed by loess within-array normal-
ization and then scale between-array normalization [67,68]. To
further eliminate genes near background in thesenormalized data we
set a median expression threshold value of 90 for either CR or
HIGHCAL. These adjustments gave a final normalized and culled
set of 8,347 genes and controls for statistical testing. For testing of
significance we used the software package, Significance Analysis of
Microarrays (SAM) and implemented the two class unpaired option
[26]. SAM computes and returns a ranked list of significant genes and
several statistics, including the modified t-statistic d,a n dt h em e d i a n
false discovery rate (FDR). The FDR increases with the number of
genes called significant and is the median number of genes falsely
called significant from all permutations divided by the number of
genes called significant at a user-specified cutoff. The q-value is the
lowest FDR at whicha given gene is called significant. For group 1 we
chose all 15 microarrays from all high-calorie-fed mice (HIGHCAL)
and for group 2 we chose all 8 CR microarrays. We included gene
duplicates and controls in the SAM procedure but removed them
after, leaving a non-redundant set of 8,347 genes.
For GenAge associations we used only mouse genes and mouse
orthologs of human genes listed in GenAge. For human genes we
conservatively used only mouse orthologs that share the same
function and assigned Entrez gene name listed in the Homologene
database (release 59). For GO classification we used the web tool
FuncAssociate [35]. FuncAssociate uses a Monte Carlo simulation
approach and returns all overrepresented GO classes for a given
set of input genes relative to the gene universe from which this
subset is derived, along with several descriptive statistics, including
P-value based on Fisher’s exact test, and adjusted P-value based on
1000 null hypothesis simulations to correct for simultaneous
testing of multiple non-independent hypotheses. We analyzed six
different sets of genes using FuncAssociate: upregulated, down-
regulated, and all genes, from both permissive and restrictive data
sets. FuncAssociate analyses were run using the unordered input
option. The input gene universe for FuncAssociate consisted of all
genes on our microarrays, which FuncAssociate culled down to a
final set of 17,851 unique genes.
Western blots and quantitative RT–PCR
For Western blots mouse livers (100 mg) were homogenized in
16 NuPAGE LDS loading buffer (cat. #NP0007, Invitrogen,
Carlsbad, CA) with 16protease inhibitor mix (cat. #8340, Sigma-
Aldrich, St. Louis, MO), 16Phosphatase Inhibitor Cocktail Set 1
(cat. #524624, Calbiochem, San Diego, CA) and 16Phosphatase
Inhibitor Cocktail Set 2 (cat. #524625, Calbiochem, San Diego,
CA). The homogenates were sonicated for 15 seconds to reduce
viscosity, and centrifuged at 15,0006g for 10 minutes to remove
insoluble material. Samples were subjected to standard SDS-
PAGE and probed by Western blot using phospho-specific
CR Feminizes Gene Expression
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Signaling Technology, Danvers, MA), phospho-p70 S6 kinase
(Thr389) (cat. #9205, Cell Signaling Technology, Danvers, MA)
and phospho-p70 S6 kinase (Thr421/Ser424) (cat. # 9204, Cell
Signaling Technology, Danvers, MA). Membranes were stripped
using Restore Western Blot Stripping Buffer (cat. #21059, Pierce
Biotechnology, Inc., Rockford, IL) for 30 minutes at 37uC, and
were reprobed with antibodies directed against total p70 S6 kinase
(cat. #9202, Cell Signaling Technology, Danvers, MA) or total
4E-BP1 (cat. #9452, Cell Signaling Technology, Danvers, MA).
Membrane bound HRP-conjugated secondary antibody was
detected using SuperSignal West Femto Maximum Sensitivity
Substrate (cat. #34095, Pierce Biotechnology, Inc., Rockford, IL).
Quantitation of protein bands was performed using Quantity One
software (Bio-Rad Laboratories, Inc., Hercules, CA).
We used quantitative RT-PCR (Q-RT-PCR) to verify micro-
array results for specific genes of interest. A listing of primers used
in Q-RT-PCR assays can be found in Table S4 and all fold-
changes can be found in Table S1. Two control transcripts
(Masp2 and D3Ucla1) were chosen; of all transcripts with high but
non-saturable expression levels, they were among the transcripts
with the lowest variance across all tested regimens. Primers that
amplify a predicted amplicon of at least 100 bases and less than
250 bases were favored over others. All of the primers for Q-RT-
PCR were designed to span exon junctions so as to avoid
amplification of any potential contaminating genomic DNA.
Nevertheless, in addition to ‘‘no RNA’’ negative control reactions
for each primer, for all RNAs we performed ‘‘no RT’’ PCR
reactions (i.e., without reverse transcriptase) in order to ensure that
there is no contaminating genomic DNA that would result in
amplification products in the Q-RT-PCRs. First strand cDNA
synthesis was performed with 10 mg of total RNA, random
hexamers, and SuperScriptIII Reverse Transcriptase (Invitrogen).
Each quantitative PCR reaction was carried out in iCycler IQ
Real-Time Detection Systems (Bio-Rad), in a total volume of
25 ml, which contained 16 iQ SyBr Green Supermix (BioRad)
and 200 nM forward and reverse primers. PCR amplification for
each cDNA sample was performed in at least triplicate wells. The
quantitative PCR conditions were as follows: 3 min at 95uC,
followed by a total of 45 three-temperature cycles (30 sec at 95uC,
30 sec at between 60.5uC and 65.0uC, and 45 sec at 72uC).
Relative gene expression data analysis was carried out with the
standard curve method [69,70], and statistical significance of fold-
changes was calculated using a t-test, requiring a P-value of at least
0.05 for significance [71,72].
Supporting Information
Table S1 Quantitative RT-PCR fold-changes and array fold-
changes for selected transcripts. Positive fold changes are ratios of
CR/HIGHCAL and negative fold changes are negative values of
ratios of HIGHCAL/CR. Unless denoted as not significant (NS)
all listed RT-PCR values are significant at P,0.05.
Found at: doi:10.1371/journal.pone.0005242.s001 (0.02 MB
XLS)
Table S2 All genes significantly changed in CR relative to
HIGHCAL. Fold changes are provided by Significance Analysis of
Microarrays (SAM) software, and are approximate values averaged
over all CRmax/HIGHCAL conditions. Negative fold changes are
represented as the negative inverse (-HIGHCAL/CRmax). Stat
Score (d) is the modified t-statistic returned by SAM. FC Rank is the
ranking of genes in descending order from largest to smallest fold
change and separate rankings are provided for upregulated and
downregulated genes. Separate statistical rankings are provided for
upregulated and downregulated genes and are combined into a
single list. q-value is given as a percent from SAM and the restrictive
set of genes comprises those with a q-value,1.0%.
Found at: doi:10.1371/journal.pone.0005242.s002 (0.75 MB
XLS)
Table S3 Significantly over-represented Gene Ontology (GO)
terms returned by FuncAssociate at an adjusted P-value cutoff of
p,0.05. GO terms are listed in descending order of significance for
each input gene set. Six sets are shown: genes UPREGULATED by
CR, genes DOWNREGULATED by CR, and the combined list of
genes both up- and DOWNREGULATED by CR, for both
statistical cutoffs, q,0.01 and q,0.1. Rank is the position in the
attribute list ranked by significance of association with the given
query; N is the number of genes in the query with this attribute; X is
thenumberof genesoverall in the query universe withthisattribute;
LOD is the natural log of the odds ratio; P is the single hypothesis
one-sided P-value of the association between attribute and query
(based on Fisher’s Exact Test); and P-adj is the adjusted P-value:
fraction (as a %) of 1000 null-hypothesis simulations having
attributes with this single-hypothesis P value or smaller.
Found at: doi:10.1371/journal.pone.0005242.s003 (0.10 MB
XLS)
Table S4 Primer sequences used for Q-RT-PCR.
Found at: doi:10.1371/journal.pone.0005242.s004 (0.02 MB
XLS)
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